Sunday, November 1, 2026

OpenAI Says ChatGPT Is Back to 10%+ Monthly Growth—And a New Model Drops This Week

OpenAI's ChatGPT has regained a 10% growth rate, with a new model launch expected this week amid competition from rivals.

No Clear Answers on Drone in North Korea’s Airspace, Says South Korean Defense Head

Director Lee Geon Wan stated it's hard to identify North Korea's claimed drone due to similar designs, denying South Korean involvement.

Seers to Highlight Earnings Growth, Global Business at Singapore NDR

Seers will use its first Singapore NDR since listing to showcase earnings growth and accelerate global expansion of its AI-powered medical monitoring and diagnostics business.

Health

Unlock Your Health: Discover the New AI-Powered BioAge and Health Coach Services from DaNaA Data

Daewoo Group's AI health data firm, DaNaA Data, launched a service analyzing biological age, disease risk, and health check results.

How the New Medical School in Namwon Can Transform Regional Healthcare: Insights from Lawmaker Park Ji-won

Defining school locations alone won't solve local healthcare issues; deeper strategies are needed for effective solutions.

Ardens Lifescience Triumphs: How a Korean Startup Won 175,000 USD at MedTech Innovator APAC 2026

Adenz Life Sciences wins a global medical device competition, earning a prize of 175,000 USD.

Unlocking the Future of Healthcare: Daewoong’s AI-Powered Smart Hospital at AI EXPO MARS 2026

Daewoong Pharmaceutical introduces an AI-based smart hospital model for monitoring, diagnosis, testing, and rehabilitation.

10 Years of Excellence: Seoul’s APLAR Center Hosts International Rheumatology Training for Young Specialists

Seoul St. Mary's Hospital's Rheumatology Center held an international training program for foreign experts on October 27 and 26.
Latest

Wegovy Breaks Records: 3 Million Prescriptions in Just 5 Months – What You Need to Know

Wegovy surpasses 3 million prescriptions in 5 months, marking a significant milestone in the U.S. obesity treatment market.

SK Bioscience Licenses CDC Rotavirus Vaccine Candidate, Expands Global Vaccine Pipeline

SK Bioscience partners with the CDC to develop a rotavirus vaccine, aiming to enhance global health and expand its vaccine portfolio.

Simple Blood Test May Identify Optimal Treatment Window for Alzheimer’s Disease, Study Finds

A blood test could pinpoint the best time to start Alzheimer's treatment, enhancing patient outcomes and reducing costs, say researchers.

Lunit Joins Nvidia AI Ecosystem Meeting to Explore Global Healthcare AI Partnerships

Lunit, a medical AI firm, will attend NVIDIA's AI Ecosystem meeting in Seoul, following CEO Jensen Huang's visit.

Ebola Outbreak in DR Congo: Why Contact Tracing is Stalling at 45%?

The Ebola contact tracing rate in DR Congo has dropped to 45%, raising alarms for outbreak control as cases surge rapidly.

DA-2811 vs. Farxiga: Which Diabetes Treatment Proves More Effective in 2026?

Dong-A ST's DA-2811 shows comparable efficacy to Farxiga in diabetes treatment, with positive clinical trial results presented at ADA.

Revolutionary Vaccine Technology: How One Shot Can Triple Immunity Duration with Mussel Protein

POSTECH has developed a single-dose vaccine technology using mussel proteins for long-lasting immunity, promising mass production potential.

IVL3021 vs Wegovy: The Future of Long-Acting Obesity Treatments Revealed

Inventage Lab's IVL3021 shows promising long-term obesity treatment results, outperforming competitors with effective weight maintenance strategies.

How GE Healthcare is Transforming the Medical Device Market with AI and Data Integration

The medical device market is shifting towards data-driven solutions, with GE Healthcare leading initiatives in AI and patient monitoring.

Daewoong’s Enavogliflozin Shows Consistent Glucose-Lowering Effects Across Korean and Chinese Patients

Daewoong's diabetes drug Enblo shows similar effects in Korean and Chinese patients, supporting its global expansion and future approvals.

ABL Bio to Showcase Dual-Target ADC Candidate ABL209 at World ADC Korea 2026

ABL Bio will showcase its dual-target ADC candidate ABL209 at the World ADC Korea 2026, focusing on enhanced cancer treatment.

SK Biopharmaceuticals Launches U.S. Innovation Hub to Help Korean Biotechs Expand Globally

SK Biopharmaceuticals launched SK Life Science LinX to support Korean biotech firms entering the U.S. market, fostering innovation and collaboration.

Bridging Clinic and Lab: Three Physician-Scientists Drive Next-Generation Liver Disease Research

Physician-scientists in Korea bridge clinical practice and research, driving innovations in patient care and biotechnology competitiveness.

Yonsei Researchers Discover Experimental Compound That Targets Drug-Resistant Metastatic Cancer Cells

A research team at Yonsei University has discovered a substance to treat resistant metastatic cancer.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.